跳至主要内容
临床试验/NCT06488066
NCT06488066撤回不适用

Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

Vance Thompson Vision1 个研究点 分布在 1 个国家开始时间: 2021年8月13日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Manifest refraction

研究概览

简要总结

The objective of this investigator initiated study (IIT-002) is to collect data on commercial patients implanted with the RxSight Light Adjustable Lens (LAL).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sign a written Informed Consent Document
  • Implanted commercially with the LAL and completed LDD light treatments

排除标准

  • Previous corneal or intraocular surgery other than removal of cataract and implantation of the LAL

结局指标

主要结局

Manifest refraction

时间窗: Pre operatively and immediately post operatively

A qualified ophthalmologist, optometrist, or a trained ophthalmic technician should obtain the refraction, in 0.25D steps, in a calibrated refraction lane. If the subject has a current pair of glasses for distance vision, they can be measured with a lensometer, and these measurements are used as the beginning approximate refraction

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Clinical Outcomes of Patients Implanted With the... | 临床试验